vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and Ultra Clean Holdings, Inc. (UCTT). Click either name above to swap in a different company.

Ultra Clean Holdings, Inc. is the larger business by last-quarter revenue ($533.7M vs $510.9M, roughly 1.0× Genius Sports Ltd). Ultra Clean Holdings, Inc. runs the higher net margin — -2.8% vs -12.3%, a 9.5% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 1.7%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Ultra Clean Holdings, Inc. is a leading global supplier of critical subsystems, ultra-high purity cleaning services, and precision process components for the semiconductor, advanced display, and life sciences sectors. It operates across North America, Asia, and Europe, serving top semiconductor fabs and high-tech equipment manufacturers to support advanced microelectronics production.

GENI vs UCTT — Head-to-Head

Bigger by revenue
UCTT
UCTT
1.0× larger
UCTT
$533.7M
$510.9M
GENI
Higher net margin
UCTT
UCTT
9.5% more per $
UCTT
-2.8%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
1.7%
UCTT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
UCTT
UCTT
Revenue
$510.9M
$533.7M
Net Profit
$-63.0M
$-15.0M
Gross Margin
25.2%
12.2%
Operating Margin
-11.5%
2.1%
Net Margin
-12.3%
-2.8%
Revenue YoY
2.9%
Net Profit YoY
-500.0%
EPS (diluted)
$-0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
UCTT
UCTT
Q1 26
$533.7M
Q4 25
$510.9M
$506.6M
Q3 25
$335.4M
$510.0M
Q2 25
$215.2M
$518.8M
Q1 25
$119.7M
$518.6M
Q4 24
$413.0M
$563.4M
Q3 24
$285.8M
$540.4M
Q2 24
$184.1M
$516.1M
Net Profit
GENI
GENI
UCTT
UCTT
Q1 26
$-15.0M
Q4 25
$-63.0M
$-3.3M
Q3 25
$-10.9M
Q2 25
$-47.3M
$-162.0M
Q1 25
$-25.5M
$-5.0M
Q4 24
$-85.5M
$16.3M
Q3 24
$-47.1M
$-2.3M
Q2 24
$-35.5M
$19.1M
Gross Margin
GENI
GENI
UCTT
UCTT
Q1 26
12.2%
Q4 25
25.2%
15.2%
Q3 25
24.2%
16.1%
Q2 25
19.1%
15.3%
Q1 25
10.7%
16.2%
Q4 24
16.7%
16.3%
Q3 24
20.5%
17.3%
Q2 24
18.6%
17.1%
Operating Margin
GENI
GENI
UCTT
UCTT
Q1 26
2.1%
Q4 25
-11.5%
2.2%
Q3 25
-15.3%
2.1%
Q2 25
-21.0%
-27.3%
Q1 25
-20.3%
2.5%
Q4 24
-18.0%
4.6%
Q3 24
-13.9%
4.7%
Q2 24
-16.8%
4.4%
Net Margin
GENI
GENI
UCTT
UCTT
Q1 26
-2.8%
Q4 25
-12.3%
-0.7%
Q3 25
-2.1%
Q2 25
-22.0%
-31.2%
Q1 25
-21.3%
-1.0%
Q4 24
-20.7%
2.9%
Q3 24
-16.5%
-0.4%
Q2 24
-19.3%
3.7%
EPS (diluted)
GENI
GENI
UCTT
UCTT
Q1 26
$-0.40
Q4 25
$-0.07
Q3 25
$-0.24
Q2 25
$-3.58
Q1 25
$-0.11
Q4 24
$0.36
Q3 24
$-0.05
Q2 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
UCTT
UCTT
Cash + ST InvestmentsLiquidity on hand
$280.6M
$323.5M
Total DebtLower is stronger
$601.9M
Stockholders' EquityBook value
$724.5M
$702.1M
Total Assets
$1.1B
$1.9B
Debt / EquityLower = less leverage
0.86×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
UCTT
UCTT
Q1 26
$323.5M
Q4 25
$280.6M
$311.8M
Q3 25
$110.2M
$314.1M
Q2 25
$110.2M
$327.4M
Q1 25
$110.2M
$317.6M
Q4 24
$100.3M
$313.9M
Q3 24
$100.3M
$318.2M
Q2 24
$100.3M
$319.5M
Total Debt
GENI
GENI
UCTT
UCTT
Q1 26
$601.9M
Q4 25
$481.4M
Q3 25
Q2 25
Q1 25
Q4 24
$499.7M
Q3 24
Q2 24
Stockholders' Equity
GENI
GENI
UCTT
UCTT
Q1 26
$702.1M
Q4 25
$724.5M
$711.0M
Q3 25
$572.4M
$709.9M
Q2 25
$572.4M
$719.4M
Q1 25
$572.4M
$872.0M
Q4 24
$573.0M
$873.6M
Q3 24
$573.0M
$857.9M
Q2 24
$573.0M
$852.3M
Total Assets
GENI
GENI
UCTT
UCTT
Q1 26
$1.9B
Q4 25
$1.1B
$1.7B
Q3 25
$792.3M
$1.7B
Q2 25
$792.3M
$1.7B
Q1 25
$792.3M
$1.9B
Q4 24
$775.7M
$1.9B
Q3 24
$775.7M
$1.9B
Q2 24
$775.7M
$1.9B
Debt / Equity
GENI
GENI
UCTT
UCTT
Q1 26
0.86×
Q4 25
0.68×
Q3 25
Q2 25
Q1 25
Q4 24
0.57×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
UCTT
UCTT
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
UCTT
UCTT
Q1 26
Q4 25
$81.9M
$8.1M
Q3 25
$-4.8M
$100.0K
Q2 25
$-1.2M
$29.2M
Q1 25
$-14.6M
$28.2M
Q4 24
$14.9M
$17.1M
Q3 24
$-9.2M
$14.9M
Q2 24
$23.2M
Free Cash Flow
GENI
GENI
UCTT
UCTT
Q1 26
Q4 25
$69.6M
$-2.0M
Q3 25
$-14.2M
$-10.9M
Q2 25
$-5.8M
$12.4M
Q1 25
$-16.0M
$15.8M
Q4 24
$11.3M
$-200.0K
Q3 24
$-11.6M
$-300.0K
Q2 24
$10.2M
FCF Margin
GENI
GENI
UCTT
UCTT
Q1 26
Q4 25
13.6%
-0.4%
Q3 25
-4.2%
-2.1%
Q2 25
-2.7%
2.4%
Q1 25
-13.4%
3.0%
Q4 24
2.7%
-0.0%
Q3 24
-4.1%
-0.1%
Q2 24
2.0%
Capex Intensity
GENI
GENI
UCTT
UCTT
Q1 26
Q4 25
2.4%
2.0%
Q3 25
2.8%
2.2%
Q2 25
2.1%
3.2%
Q1 25
1.2%
2.4%
Q4 24
0.9%
3.1%
Q3 24
0.9%
2.8%
Q2 24
2.5%
Cash Conversion
GENI
GENI
UCTT
UCTT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.05×
Q3 24
Q2 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

UCTT
UCTT

Products$465.7M87%
Services$68.0M13%

Related Comparisons